India’s Leading Strategy Conference for Industry Executives
Life Science | Biotech | Pharma | Bio Services | Digital Healthcare | Medtech
Through the most universally crippling pandemic of all time, the Pharma and Biotech sectors have taken a real ownership role in finding solutions, working in collaboration with scientific experts, academia, and governments to help diagnose, treat, and prevent further spreads. A state of ‘new normal’ has emerged in all facets of the biopharma endeavors. Being ever-present digitally for all the key connects of the business is a trend that will define success more than ever.
While the pharmaceutical business has been in the spotlight during the pandemic for its key job in creating medicines and immunizations to COVID-19, in the background the worldwide crisis is filling in as a quickening agent for some patterns that were at that point changing the manner in which pharma worked. We've addressed key companies from across pharma to see how their organizations are adjusting to COVID-19.
What's obvious from this activity is the drive to be more client oriented and move towards connecting with them via automated and remote means that have emerged in the recent times.